Sagent Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference

SCHAUMBURG, Ill., Sept. 16, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that President, Chief Executive Officer and founder Jeffrey M. Yordon will present at the UBS Global Life Sciences Conference on September 20, 2011 at 8:30 a.m. Eastern Time.
MORE ON THIS TOPIC